LOH at 3p correlates with a poor survival in oral squamous cell carcinoma

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 366-371

  Partridge, M ^a   Emilion, G ^a   Langdon, J D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chromosome deletion; Genes; Mouth neoplasms; Oral cancer; Suppressor; Tumour

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 3P; CHROMOSOME MAP; CLINICAL ARTICLE; FEMALE; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MARKER GENE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 0030070862     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.62     Document Type: Article

References (24)

1. AH-SEE KW, COKE TG, PICKFORD IR, SOUTAR D AND BALMAIN A. (1994). An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res., 54, 1617-1621.
2. CARR RJ AND LANGDON JD. (1989). Multiple primaries in mouth cancer. Br. J. Oral Maxillofacial Surg., 27, 394-399.
3. CHEN L-C, MATSUMURA K, DENG G, KURISU W, LJUNG B-M, LERMAN MI., WALDMAN FM AND SMITH HS. (1994). Deletion of two separate regions on chromosome 3p in breast cancer. Cancer Res., 54, 3021-3024.
4. EMILION G, LANGDON JD, SPEIGHT P AND PARTRIDGE M. (1996). Frequent gene deletions in potentially malignant oral lesions. Br. J. Cancer., (in Press).
5. FEARON ER AND VOGELSTEIN B. (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
6. HENK JM AND LANGDON JD. (1994). Carcinoma of the oral cavity-management of the primary tumour. In Malignant Tumours of the Mouth, Jaws and Salivary Glands. Langdon JD, Henk JM (eds) pp. 154-156. Edward Arnold: London.
7. HIBI K, TAKAHASHI K, YAMAKAWA K, UEDA R, SEKIDO Y, ARIYOSHI Y, SUYAMA M, TAKAGI H, NAKAMURA Y AND TAKAHASHI T. (1993). Three distinct regions involved in 3p deletion in lung cancer. Oncogene, 7, 445-449.
8. HIRATA RM, JAQUES DA, CHAMBERS RG, TUTTLE JR AND MAHONEY WE. (1975). Carcinoma of the oral cavity. An analysis of 478 cases. Ann. Surg., 182, 98-106.
9. JONES MH AND NAKAMURA Y. (1992). Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene, 7, 1631-1634.
10. KOHNO T, TAKAYAMA H, HAMAGUCHI M, TAKANO H, YAMAGUCHI N, TSUDA H, HIROHASHI S, VISSING H, SHIMIZU M, OSHIMURA M AND YOKOTA J. (1993). Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene, 8, 1825-1832.
11. LAFORGIA S, MORSE B, LEVY J, BARNEA G, CANNIZZARO LA, LI F, NOWELL PC, BOGHOSIAN-SELL L, GLICK J., WESTON A, HARRIS CC, DRABKIN H, PATTERSON D, CROCE CM, SCHLESSINGER J AND HUEBNER K. (1991). Receptor protein-tyrosine phosphatase γ is a candidate tumour suppressor gene at human chromosome region 3p21. Proc. Natl Acad. Sci. USA, 88, 5036-5040.
12. LI X, LEE NK, YE Y-W, WABER PG, SCHWEITZER C, CHENG Q-C AND NISEN PD. (1994). Allelic loss at chromosomes 3p, 8p, 13q and 17p associated with poor prognosis in head and neck cancer. J. Natl Cancer Inst., 86, 1524-1530.
13. LUNA MA. (1983). Oral communication, quoted by Goopfert H. In, Are we making progress? Arch. Otolaryngol., 110, 563-564.
14. MAESTRO R, GASPAROTTO D, VUKOSAVLJEVIC T, BARZAN L, SULFARO S AND BOIOCCHI M. (1993). Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res., 53, 1-5.
15. MATTEI M-G, DE THE H, MATTEI JF, MARCHIO A, TIOLLAIS P AND DEJEAN A. (1988). Assignment of the human hap retinoic acid receptor RARβ gene to the band p24 of chromosome 3. Hum. Genet., 80, 188-189.
16. NARWOZ H, VAN DER REIT P, HRUBAN RH, KOCH W, RUPPERT JM AND SIDRANSKY D. (1994). Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54, 1152-1155.
17. NAYLOR SL, BUYS CHCM AND CARRITT B. (1994). Report of the Fourth Single Chromosome Workshop. Cytogenet. Cell Genet., 65, 1-38.
18. PARTRIDGE M, KIGUWA S AND LANGDON JD. (1994). Frequent deletion of chromosome 3p in oral squamous cell carcinoma. Oral Oncol. Eur. J. Cancer, 30B, 248-252.
19. SANCHEZ Y, EL-NAGGAR A, PATHAK S AND MCNEILL KILLARY A. (1994). A tumour suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo. Proc. Natl. Acad. Sci. USA, 91, 3383-3387.
20. SHUIN T, KONDO K, TORIGOE S, KISHIDA T, KUBOTA Y, HOSAKA M, NAGASHIMA Y, KITAMURA H, LATIF F, ZBAR B, LERMAN MI AND YAO M. (1994). Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumour suppressor gene in primary human renal cell carcinomas. Cancer Res., 54, 2852-2856.
21. SUNDARESAN V, GANLY P, HASLETON P, RUDD R, SINHA G, BLEEHAN NM AND RABBITTS P. (1992). p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in pre-invasive lesions of the bronchus. Oncogene, 7, 1989-1997.
22. WRIGHT DK AND MANOS MM. (1990). In PCR Protocols: a Guide to Methods and Applications, Wright DK and Manos MM (eds) pp. 152-158, Academic Press: San Diego.
23. WU CL, SLOAN P, READ AP, HARRIS R AND THAKKER N. (1994). Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res., 54, 6484-6488.
24. YOKOTA J, TSUKADA Y, NAKAJIMA T, GOTOH M, SHIMOSATO Y, MORI N, TSUNOKAWA Y, SUGIMURA T AND TERADA M. (1989). Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res., 49, 3598-3601.